Organization | National Research Agency, France

National Research Agency, France Report issue

Government Phase 2 Phase 4

Founded: Paris France (2005)

Organization Overview

First Clinical Trial

2005

NCT01154608

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

National Research Agency, France

Active Ingredients

Drugs in Phase 4 Trials (1)

disulfiram (antabuse) (1 trial)

Drugs in Phase 2 Trials (1)

p28gst (1 trial)

Drugs in Other Trials (9)

cyproviron (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

milk protein (1 trial)

norgestrel (Ovral) (1 trial)

pancrelipase (creon) (1 trial)

soy protein (1 trial)

tryptophan (1 trial)

vigabatrin (sabril) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Cocaine-Related Disorders (Phase 4)

Crohn Disease (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 11